Katherine Cashen1, Ron Reeder, Heidi J Dalton, Robert A Berg, Thomas P Shanley, Christopher J L Newth, Murray M Pollack, David Wessel, Joseph Carcillo, Rick Harrison, J Michael Dean, Tammara Jenkins, Kathleen L Meert. 1. 1Division of Critical Care, Department of Pediatrics, Children's Hospital of Michigan/Wayne State University, Detroit, MI. 2Department of Pediatrics, University of Utah, Salt Lake City, UT. 3Department of Child Health, Phoenix Children's Hospital, Phoenix, AZ. 4Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, Philadelphia, PA. 5Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI. 6Department of Anesthesiology and Critical Care Medicine, Children's Hospital Los Angeles, Los Angeles, CA. 7Department of Pediatrics, Children's National Medical Center, Washington, DC. 8Department of Critical Care Medicine, Children's Hospital of Pittsburgh, Pittsburgh, PA. 9Department of Pediatrics, Mattel Children's Hospital UCLA, Los Angeles, CA. 10Pediatric Trauma and Critical Illness Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.
Abstract
OBJECTIVES: To describe functional status at hospital discharge for neonatal and pediatric patients treated with extracorporeal membrane oxygenation, and identify factors associated with functional status and mortality. DESIGN: Secondary analysis of observational data collected by the Collaborative Pediatric Critical Care Research Network between December 2012 and September 2014. SETTING: Eight hospitals affiliated with the Collaborative Pediatric Critical Care Research Network. PATIENTS: Patients were less than 19 years old and treated with extracorporeal membrane oxygenation. INTERVENTIONS: Functional status was evaluated among survivors using the Functional Status Scale. Total Functional Status Scale scores range from 6 to 30 and are categorized as 6-7 (good), 8-9 (mildly abnormal), 10-15 (moderately abnormal), 16-21 (severely abnormal), and greater than 21 (very severely abnormal). MEASUREMENTS AND MAIN RESULTS: Of 514 patients, 267 (52%) were neonates (≤ 30 d old). Indication for extracorporeal membrane oxygenation was respiratory for 237 (46%), cardiac for 207 (40%), and extracorporeal cardiopulmonary resuscitation for 70 (14%). Among 282 survivors, 89 (32%) had good, 112 (40%) mildly abnormal, 67 (24%) moderately abnormal, and 14 (5%) severely or very severely abnormal function at hospital discharge. Among neonates, development of renal failure and longer hospitalization were independently associated with worse Functional Status Scale. Chronic conditions, prematurity, venoarterial extracorporeal membrane oxygenation, increased red cell transfusion in the first 24 hours of extracorporeal membrane oxygenation, and longer extracorporeal membrane oxygenation duration were independently associated with mortality. Among pediatric patients, chronic neurologic conditions, tracheostomy or home ventilator, extracorporeal cardiopulmonary resuscitation, hepatic dysfunction, and longer ICU stay were independently associated with worse Functional Status Scale. Chronic cardiac conditions, hepatic dysfunction, and neurologic or thrombotic complications were independently associated with mortality. Achieving blood lactate concentration less than or equal to 2 mmol/L during extracorporeal membrane oxygenation was independently associated with survival in both neonatal and pediatric patients. CONCLUSIONS: In this study, about half of extracorporeal membrane oxygenation patients survived with good, mildly abnormal, or moderately abnormal function at hospital discharge. Patient and extracorporeal membrane oxygenation-related factors are associated with functional status and mortality.
OBJECTIVES: To describe functional status at hospital discharge for neonatal and pediatric patients treated with extracorporeal membrane oxygenation, and identify factors associated with functional status and mortality. DESIGN: Secondary analysis of observational data collected by the Collaborative Pediatric Critical Care Research Network between December 2012 and September 2014. SETTING: Eight hospitals affiliated with the Collaborative Pediatric Critical Care Research Network. PATIENTS: Patients were less than 19 years old and treated with extracorporeal membrane oxygenation. INTERVENTIONS: Functional status was evaluated among survivors using the Functional Status Scale. Total Functional Status Scale scores range from 6 to 30 and are categorized as 6-7 (good), 8-9 (mildly abnormal), 10-15 (moderately abnormal), 16-21 (severely abnormal), and greater than 21 (very severely abnormal). MEASUREMENTS AND MAIN RESULTS: Of 514 patients, 267 (52%) were neonates (≤ 30 d old). Indication for extracorporeal membrane oxygenation was respiratory for 237 (46%), cardiac for 207 (40%), and extracorporeal cardiopulmonary resuscitation for 70 (14%). Among 282 survivors, 89 (32%) had good, 112 (40%) mildly abnormal, 67 (24%) moderately abnormal, and 14 (5%) severely or very severely abnormal function at hospital discharge. Among neonates, development of renal failure and longer hospitalization were independently associated with worse Functional Status Scale. Chronic conditions, prematurity, venoarterial extracorporeal membrane oxygenation, increased red cell transfusion in the first 24 hours of extracorporeal membrane oxygenation, and longer extracorporeal membrane oxygenation duration were independently associated with mortality. Among pediatric patients, chronic neurologic conditions, tracheostomy or home ventilator, extracorporeal cardiopulmonary resuscitation, hepatic dysfunction, and longer ICU stay were independently associated with worse Functional Status Scale. Chronic cardiac conditions, hepatic dysfunction, and neurologic or thrombotic complications were independently associated with mortality. Achieving blood lactate concentration less than or equal to 2 mmol/L during extracorporeal membrane oxygenation was independently associated with survival in both neonatal and pediatric patients. CONCLUSIONS: In this study, about half of extracorporeal membrane oxygenation patients survived with good, mildly abnormal, or moderately abnormal function at hospital discharge. Patient and extracorporeal membrane oxygenation-related factors are associated with functional status and mortality.
Authors: Tellen D Bennett; Rebecca R Dixon; Cory Kartchner; Peter E DeWitt; Yamila Sierra; Diane Ladell; Allison Kempe; Desmond K Runyan; J Michael Dean; Heather T Keenan Journal: Pediatr Crit Care Med Date: 2016-12 Impact factor: 3.624
Authors: Mackenzie A Ford; Kimberlee Gauvreau; D Michael McMullan; Melvin C Almodovar; David S Cooper; Peter T Rycus; Ravi Thiagarajan Journal: Pediatr Crit Care Med Date: 2016-09 Impact factor: 3.624
Authors: T K Susheel Kumar; David Zurakowski; Heidi Dalton; Sachin Talwar; Ayana Allard-Picou; Lennart F Duebener; Pranava Sinha; Achintya Moulick Journal: J Thorac Cardiovasc Surg Date: 2010-08 Impact factor: 5.209
Authors: Michael G Gaies; James G Gurney; Alberta H Yen; Michelle L Napoli; Robert J Gajarski; Richard G Ohye; John R Charpie; Jennifer C Hirsch Journal: Pediatr Crit Care Med Date: 2010-03 Impact factor: 3.624
Authors: Murray M Pollack; Richard Holubkov; Tomohiko Funai; Amy Clark; Frank Moler; Thomas Shanley; Kathy Meert; Christopher J L Newth; Joseph Carcillo; John T Berger; Allan Doctor; Robert A Berg; Heidi Dalton; David L Wessel; Rick E Harrison; J Michael Dean; Tammara L Jenkins Journal: JAMA Pediatr Date: 2014-07 Impact factor: 16.193
Authors: Murray M Pollack; Richard Holubkov; Tomohiko Funai; Amy Clark; John T Berger; Kathleen Meert; Christopher J L Newth; Thomas Shanley; Frank Moler; Joseph Carcillo; Robert A Berg; Heidi Dalton; David L Wessel; Rick E Harrison; Allan Doctor; J Michael Dean; Tammara L Jenkins Journal: Pediatr Crit Care Med Date: 2014-11 Impact factor: 3.624
Authors: Francesc Torres-Andres; Ericka L Fink; Michael J Bell; Mahesh S Sharma; Eric J Yablonsky; Joan Sanchez-de-Toledo Journal: Pediatr Crit Care Med Date: 2018-05 Impact factor: 3.624
Authors: Katherine Cashen; Ron W Reeder; Christina Shanti; Heidi J Dalton; J Michael Dean; Kathleen L Meert Journal: Perfusion Date: 2017-12-11 Impact factor: 1.972
Authors: Kathleen L Meert; Anne-Marie Guerguerian; Ryan Barbaro; Beth S Slomine; James R Christensen; John Berger; Alexis Topjian; Melania Bembea; Sarah Tabbutt; Ericka L Fink; Steven M Schwartz; Vinay M Nadkarni; Russell Telford; J Michael Dean; Frank W Moler Journal: Crit Care Med Date: 2019-03 Impact factor: 7.598
Authors: Friedrich Reiterer; Elisabeth Resch; Michaela Haim; Ute Maurer-Fellbaum; Michael Riccabona; Gerfried Zobel; Berndt Urlesberger; Bernhard Resch Journal: Front Pediatr Date: 2018-09-25 Impact factor: 3.418
Authors: Ryan P Barbaro; Yuejia Xu; Santiago Borasino; Edward J Truemper; R Scott Watson; Ravi R Thiagarajan; David Wypij; Martha A Q Curley Journal: Am J Respir Crit Care Med Date: 2018-05-01 Impact factor: 30.528
Authors: Hanneke IJsselstijn; Maayke Hunfeld; Raisa M Schiller; Robert J Houmes; Aparna Hoskote; Dick Tibboel; Arno F J van Heijst Journal: Front Pediatr Date: 2018-06-26 Impact factor: 3.418
Authors: Vivianne Camila de Souza Bastos; Arthur Augusto Lima Carneiro; Marina Dos Santos Ramos Barbosa; Lívia Barboza de Andrade Journal: Rev Bras Ter Intensiva Date: 2018-09-03